99% Savings - Buy Urjas Massage Oil Just @1 Rs X
Amikacin + Cefepime is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Based on research, the following side effects have been observed when Amikacin + Cefepime is used -
Moderate
Mild
Unknown
Is the use of Amikacin + Cefepime safe for pregnant women?
There are no side effects of Amikacin + Cefepime in pregnant women.
Is the use of Amikacin + Cefepime safe during breastfeeding?
Side effects of Amikacin + Cefepime for breastfeeding are little to none, so you can take it without doctor's advice.
What is the effect of Amikacin + Cefepime on the Kidneys?
Very few cases of side effects of Amikacin + Cefepime on kidney have been reported.
What is the effect of Amikacin + Cefepime on the Liver?
Amikacin + Cefepime is not harmful for the liver.
What is the effect of Amikacin + Cefepime on the Heart?
Amikacin + Cefepime is not harmful for the heart.
Amikacin + Cefepime should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Amikacin + Cefepime unless your doctor advises you to do so -
Is this Amikacin + Cefepime habit forming or addictive?
No, there is no any evidence that Amikacin + Cefepime is addictive.
Interaction between Food and Amikacin + Cefepime
Taking Amikacin + Cefepime with food does not cause any problems.
Interaction between Alcohol and Amikacin + Cefepime
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Amikacin + Cefepime.
No, Amikacin + Cefepime is not available in tablet form. It is available in only injectable dosage form either given by intramuscularly or intravenously depends on patient condition or severity of infections.
Yes, Amikacin + Cefepime is safe to use, if taken in prescribed amount and duration as advised by the doctor. However, certain side effects have been associated with this drug such as decreased urination, itching, irritation, and hearing loss. If you experience above-mentioned side after consuming this medicine then inform your doctor and follow his/her instructions.
Amikacin + Cefepime is a prescription drug, hence do not take Amikacin + Cefepime without consulting doctor. It can be harmful to patients to take this medicine without a doctor's advice.
Yes, Amikacin + Cefepime has been reported to cause ototoxicity (hearing loss or deafness) which is irreversible and may progress after discontinuation of the drug. It is a common side effect of this medicine. If you experience hearing loss or deafness after consuming or applying for this medicine, then consult your doctor and follow his/her instructions.
Yes, Amikacin + Cefepime is nephrotoxic. Nephrotoxicity depends on dose and duration of therapy. Thus, nephrotoxicity is likely to occur if Amikacin + Cefepime taken a high dose for a long time or may occur if the drug is given to a patient that already suffer from kidney problem. Nephrotoxicity associated with this drug may reduce or minimize by taking some precaution before consuming this drug like monitor kidney functions regularly and do not take it in high doses. Avoid taking Amikacin + Cefepime with another nephrotoxic drug. If you notice any urine discoloration after taking this drug then inform your doctor immediately.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Arikayce (amikacin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 749
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 136-137
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 291-292
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 729
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Maxipime™ (Cefepime Hydrochloride)